Navigation Links
American Pacific to Release Financial Results and Hold Fiscal 2008 Third Quarter Investor Teleconference
Date:7/29/2008

LAS VEGAS, July 29 /PRNewswire-FirstCall/ -- American Pacific Corporation (Nasdaq: APFC) today announced that it will release its Fiscal 2008 third quarter financial results on Tuesday, August 5, 2008. John R. Gibson, Chairman and Chief Executive Officer, invites you to participate in a teleconference to review the financial results and outlook of the Company.

The teleconference will be held Tuesday, August 5, 2008 at 1:30 p.m. PDT. To access the call please dial (973) 582-2852 and reference conference ID #58118598. Following a short presentation by Mr. Gibson and Dana M. Kelley, Vice President, Chief Financial Officer and Treasurer, there will be a Q&A session. Also present on the call will be Joseph Carleone, President and Chief Operating Officer.

The teleconference will be simultaneously webcast via Thomson Financial's First Call Events. A link to the live webcast will be available at the Company's website at http://www.apfc.com and will remain available for replay through December 2008.

American Pacific is a leading manufacturer of specialty and fine chemicals within its focused markets, as well as propulsion products sold to defense, aerospace and pharmaceutical end markets. Our products provide access to, and movement in, space via solid fuel and propulsion thrusters and represent the key active ingredient in drug applications such as HIV, epilepsy and cancer. We also produce specialty chemicals utilized in various applications such as fire extinguishing systems, as well as manufacture water treatment equipment. Our products are designed to meet customer specifications and often must meet certain governmental and regulatory approvals. Additional information about American Pacific can be obtained by visiting the Company's web site at http://www.apfc.com.


'/>"/>
SOURCE American Pacific Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Cepheid Introduces GeneXpert(R) Infinity-48 System at 2008 American Association of Clinical Chemistry Meeting
2. American Oriental Bioengineering, Inc. to Report Second Quarter 2008 Financial Results
3. Pennsylvania Governor Rendell Breaks Ground for Global Pharmaceutical Services Companys North American Headquarters
4. American Oriental Bioengineering Proposes Offering of $85 Million of Convertible Notes
5. American Telugu Association's Convention Attracts Over 10,000 People in the U.S.
6. Covert Torture, Surveillance Jeopardizes the Freedom of American Citizens
7. TorreyPines Therapeutics to Present Tezampanel Phase IIb Clinical Data for Acute Migraine at 50th Annual Scientific Meeting of the American Headache Society
8. 17th Annual Congress on Womens Health To Be Held March 27-29, 2009 in Collaboration with American Medical Womens Association (AMWA)
9. Ten Latin American Scientists Named 2008 Pew Fellows in the Biomedical Sciences
10. American Oriental Bioengineering Appoints Anindya Chatterjee to Chief Strategy Officer
11. American Oriental Bioengineering Announces that it Withdraws Convertible Preferred Stock Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)...  Vyriad Inc. announced today the appointment of ... Directors. "We are delighted to welcome Al ... develop our oncolytic viruses as the next generation of ... , MD, PhD, CEO of Vyriad. "Al and his ... passion for making a difference for cancer patients—their philanthropy ...
(Date:12/7/2016)... Texas , Dec. 7, 2016  Genprex, ... of revolutionary immunogene therapy treatments, today announced that ... practice within a leading strategic communications and advisory ... communications program. The program will combine investor relations, ... objective of raising the profile of Genprex and ...
(Date:12/7/2016)... BOULDER, Colo. , Dec. 7, 2016  Muse ... genome engineering technologies, today announced that Dr. Kevin ... member of the Board of Directors. ... , who becomes the company,s Chief Science Officer as ... and Executive Director of the BioDesign Center at the ...
(Date:12/7/2016)... ANN ARBOR, Mich. , Dec. 7, 2016 /PRNewswire/ ... immune modulatory medicines, announced today the initiation of a ... candidate, LYC-30937- E nteric C oated, in patients ... that is estimated to affect as many as 7.5 million ... with approximately 1.5 - 3 million cases being diagnosed ...
Breaking Biology Technology:
(Date:12/7/2016)... 2016   Avanade is helping Williams Martini ... in history, exploit biometric data in order to critically ... the competitive edge against their rivals after their impressive, ... Avanade has worked with Williams during the 2016 season ... (heart rate, breathing rate, temperature and peak acceleration) for ...
(Date:12/7/2016)... , Dec. 7, 2016   Veridium , ... the appointment of new CEO James Stickland ... with decades of experience, has served in senior ... where he specialized in expanding a pipeline of ... portfolios. He most recently served as managing director ...
(Date:12/6/2016)...  Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) (the ... €500.0 million principal amount of its 1.414% senior unsecured notes ... senior unsecured notes due 2026. The closing ... subject to the satisfaction of customary closing conditions.  The notes ... The Company intends to use the net proceeds ...
Breaking Biology News(10 mins):